MyAverix Finance
NS · Pharmaceuticals
Alivus Life Sciences Ltd (ALIVUS)
Pharmaceuticals & Biotechnology
Alivus Life Sciences Ltd (ALIVUS) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $137.12B, P/E ratio is 24.29, net margin is 20.7%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for ALIVUS
Alivus Life Sciences Ltd (ALIVUS) — FAQ
What is Alivus Life Sciences Ltd's market cap?
Alivus Life Sciences Ltd (ALIVUS) has a reported market cap of $137.12B (data as of 2026-07-10).
What is ALIVUS's P/E ratio?
The price-to-earnings (P/E) ratio for Alivus Life Sciences Ltd (ALIVUS) is 24.29 (data as of 2026-07-10).
Does Alivus Life Sciences Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Alivus Life Sciences Ltd (ALIVUS). Check the MyAverix Finance app for the latest dividend data.
What sector is Alivus Life Sciences Ltd in?
Alivus Life Sciences Ltd (ALIVUS) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).
What exchange is ALIVUS listed on?
ALIVUS is listed on NS.
What is Alivus Life Sciences Ltd's net margin?
Alivus Life Sciences Ltd (ALIVUS) reports a net margin of 20.7% (data as of 2026-07-10).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.